Loading…
Cumberland Pharmaceuticals Inc. is projected to rise to $8.85 by 2027, a +49% move from its current price of $5.93. CPIX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $5.69 | $5.93 | $6.19 | +0.07% |
| Jul 14 | $5.60 | $5.94 | $6.30 | +0.15% |
| Jul 15 | $5.53 | $5.94 | $6.39 | +0.22% |
| Jul 16 | $5.47 | $5.95 | $6.46 | +0.30% |
| Jul 17 | $5.43 | $5.95 | $6.53 | +0.37% |
| Jul 18 | $5.38 | $5.96 | $6.59 | +0.44% |
| Jul 19 | $5.34 | $5.96 | $6.65 | +0.52% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.34 | $5.96 | $6.65 | +0.52% |
| Week 2 | $5.13 | $5.99 | $7.00 | +1.04% |
| Week 3 | $4.98 | $6.02 | $7.28 | +1.57% |
| Week 4 | $4.86 | $6.05 | $7.54 | +2.09% |
| Week 5 | $4.76 | $6.09 | $7.77 | +2.62% |
| Week 6 | $4.68 | $6.12 | $8.00 | +3.16% |
| Week 7 | $4.60 | $6.15 | $8.22 | +3.69% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company that focuses on the acquisition, development, and commercialization of prescription products. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.
It serves hospital acute care, gastroenterology, and oncology markets in the United States, China, South Korea, Russia, Mexico, Australia, and Saudi Arabia. The product portfolio includes Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, Vibativ, and Tacilia, and it also develops ifetroban, a product candidate that has completed Phase II clinical trials for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy, hepatorenal syndrome, portal hypertension, aspirin-exacerbated respiratory disease, systemic sclerosis, and idiopathic pulmonary fibrosis. The company has a strategic alliance agreement with WinHealth Pharma Group Co.
Limited.
Cumberland Pharmaceuticals Inc. (CPIX) currently trades at $6.16 with a market capitalization of $92.3M. The company is ranked 4196 in market size. The current price sits at a level that aligns with a broader forecast path showing growth through the coming years, with a 30-day forecast range spanning from $2.80 to $9.91 in 2026 and rising toward higher averages in subsequent years.
The long-range forecast projects substantial upside, with an average price of $12.56 by 2030, $51.80 by 2040, and $123.68 by 2050, accompanied by strong ROI figures. Overall, the outlook indicates meaningful long-term upside potential, though these are estimates and not guarantees.
A major floor 52.8% below — a decisive break under it would weaken the trend.
The nearest floor, 7.6% below — buyers have tended to step in here.
The nearest ceiling, 20.2% above — a clean break opens room to run.
A major ceiling 32.0% above — clearing it would confirm fresh momentum.
Key CPIX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CPIX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.13 | Sell | $6.14 | Sell |
| MA 10 | $6.42 | Sell | $6.20 | Sell |
| MA 20 | $6.08 | Sell | $6.09 | Sell |
| MA 50 | $5.56 | Buy | $5.54 | Buy |
| MA 100 | $4.51 | Buy | $4.90 | Buy |
| MA 200 | $3.92 | Buy | $4.32 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.38 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -26.58 | Neutral |
| Williams %R (14) | -76.92 | Info |
| MACD (12,26,9) | -0.08 | Sell |
| ROC (12) | 1.72 | Buy |
| Bollinger %B (20,2) | 0.42 | Neutral |
| Stochastic %K (14) | 23.08 | Neutral |
| TRIX (15) | 0.70 | Buy |
| Awesome (5,34) | 0.18 | Buy |
| Ultimate (7,14,28) | 43.03 | Neutral |
| Momentum (10) | -0.03 | Sell |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 5.95 | Sell |
| ADX (14) | 20.74 | Sell |
| ATR (14) | 0.23 | Info |
The 30-day technical picture is labeled as BULLISH in the forecast data. The RSI14 is 50, indicating neutral momentum around mid-range levels. The SMA50 is $5.40 and the SMA200 is $3.86, providing nearby support and longer-term context for price movement.
Key support is listed at $5.48 and resistance at $7.13, framing a near-term trading band consistent with a constructive setup. The 30-day range spans from $4.56 to $8.33, illustrating the near-term volatility profile. An annualized volatility of 90% further characterizes the price swings to expect in the period ahead.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.80 | $5.93 | $9.11 | 0% | Neutral | |
| $6.71 | $8.85 | $12.54 | +49% | Bullish | |
| $7.20 | $9.94 | $14.83 | +68% | Bullish | |
| $6.91 | $9.90 | $15.38 | +67% | Bullish | |
| $7.28 | $10.79 | $17.34 | +82% | Bullish | |
| $8.42 | $12.87 | $21.29 | +117% | Bullish | |
| $10.35 | $16.30 | $27.66 | +175% | Bullish | |
| $12.55 | $20.32 | $35.29 | +243% | Bullish | |
| $12.46 | $20.73 | $36.78 | +250% | Bullish | |
| $12.44 | $21.23 | $38.42 | +258% | Bullish | |
| $18.77 | $36.19 | $71.04 | +510% | Bullish | |
| $34.08 | $75.73 | $166.92 | +11.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.80 | $5.93 | $7.07 | +0.00% |
| August 2026 | $4.95 | $5.93 | $7.35 | +0.04% |
| September 2026 | $5.24 | $6.34 | $7.99 | +6.94% |
| October 2026 | $5.31 | $6.49 | $8.29 | +2.29% |
| November 2026 | $5.27 | $6.49 | $8.39 | +0.06% |
| December 2026 | $5.63 | $6.98 | $9.11 | +7.48% |
Click any year to see its month-by-month CPIX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Cumberland Pharmaceuticals Inc.'s 2026 outlook centres on $5.93, within a $2.80 to $9.11 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, CPIX could reach as high as $12.54, with a base case around $8.85 and support toward $6.71 — roughly +49% from $5.93. Momentum favours further upside here.
Expect CPIX to range from $7.20 to $14.83 through 2028. The $9.94 average target implies a +68% move from current prices. That is up +12% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The CPIX price prediction for 2029 points to an average of $9.90 (low $6.91, high $15.38) — a potential gain of +67% on today's $5.93. Momentum favours further upside here.
In 2030, CPIX is projected to trade between $7.28 and $17.34, averaging $10.79 — a potential gain of +82% from today's $5.93. That is up +9% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Cumberland Pharmaceuticals Inc.'s 2031 outlook centres on $12.87, within a $8.42 to $21.29 range. That is up +19% on the projected 2030 average. That marks a +117% change versus current levels. Momentum favours further upside here.
By 2032, CPIX could reach as high as $27.66, with a base case around $16.30 and support toward $10.35 — roughly +175% from $5.93. Buyers look set to stay in control over this stretch.
Expect CPIX to range from $12.55 to $35.29 through 2033. The $20.32 average target implies a +243% move from current prices. That is up +25% on the projected 2032 average. Momentum favours further upside here.
The CPIX price prediction for 2034 points to an average of $20.73 (low $12.46, high $36.78) — a potential gain of +250% on today's $5.93. Buyers look set to stay in control over this stretch.
In 2035, CPIX is projected to trade between $12.44 and $38.42, averaging $21.23 — a potential gain of +258% from today's $5.93. That is up +2% on the projected 2034 average. Momentum favours further upside here.
Cumberland Pharmaceuticals Inc.'s 2040 outlook centres on $36.19, within a $18.77 to $71.04 range. That is up +70% on the projected 2035 average. That marks a +510% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, CPIX could reach as high as $166.92, with a base case around $75.73 and support toward $34.08 — roughly +11.8x from $5.93. Momentum favours further upside here.
Investing $1,000 in CPIX today (≈ 168.634064 CPIX) could be worth
$12,770.95
+$11,770.95 (+1177%) by 2050 · US Dollar
Based on the average projected CPIX price of $75.73 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CPIXwould be worth at today's price.
$1,000 invested in CPIX on Jul 10, 2025 (≈ 299.401205 CPIX) would be worth
$1,775.45
+$775.45 (+77.5%) today · 1.78× · US Dollar
Based on a CPIX entry price of $3.34 vs. today's $5.93.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.37 | $930.93 | -6.9% |
| 1 month ago | $5.48 | $1,082.12 | +8.2% |
| 3 months ago | $3.09 | $1,919.09 | +91.9% |
| 6 months ago | $4.72 | $1,256.36 | +25.6% |
| 1 year ago | $3.34 | $1,775.45 | +77.5% |
| All time (5.0y) ago | $3.33 | $1,780.78 | +78.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CPIX forecast.
Our base-case forecast reaches $12.00 around 2031.
Implied market cap at $12.00: $179.8M
The multi-year forecast paints a steadily bullish trajectory with meaningful upside potential later in the horizon. In 2030, the forecast shows an average price of $12.56 with a minimum of $8.21 and a maximum of $20.78, delivering an estimated ROI of 104% and a bullish sentiment. By 2040, the average is projected to be $51.80 with a range from $24.95 to $106.08, supporting an ROI of 740.9% and continuing bullish momentum.
In 2050, the average price is forecast at $123.68 with a range from $55.66 to $284.47, corresponding to an ROI of 1907.8% and a bullish outlook across the long horizon. These figures illustrate substantial long-term upside potential, but it is important to recognize that these are estimates and not guarantees, subject to market and company-specific risks.
Tap a question to reveal the answer.
In 2030 the forecast shows an average price of $12.56 with a min of $8.21 and a max of $20.78, delivering an estimated ROI of 104% and a bullish sentiment.
The forecast exhibits bullish sentiment from 2027 onward with rising averages: 2027 avg $9.56, 2028 avg $10.98, 2029 avg $11.27, and 2030 avg $12.56 (ROI 104%). The path continues to 2040 (avg $51.80, ROI 740.9%) and 2050 (avg $123.68, ROI 1907.8%), though these are estimates, not guarantees.
Yes. The 2040 forecast shows an average of $51.80 and a max of $106.08, indicating a path that surpasses $50 on the way to that year.
Current price is $6.16 and market cap is $92.3M.
Sentiment: BULLISH; RSI14: 50; SMA50: $5.40; SMA200: $3.86; Support: $5.48; Resistance: $7.13. The 30-day range is $4.56 to $8.33, with annualized volatility at 90%.
Cumberland Pharmaceuticals Inc. Community Discussion
0Share your Cumberland Pharmaceuticals Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.